Navigation Links
Research Foundation for Tick-Borne Infections Fights Lyme Disease, Babesiosis and Encephalitis with Pilot Studies
Date:2/15/2013
Wilton, CT (PRWEB) February 15, 2013
The National Research Fund for Tick-Borne Diseases (NRFTD) has announced grant awards totaling $240,000 to four investigators in North America to study key aspects of Lyme disease, babesiosis and Powassan encephalitis. The NRFTD is the nation's only non-profit organization dedicated solely to funding scientific research in the rapidly expanding field of tick-borne infections.
“We continue to receive remarkably innovative applications,” said Carl Brenner of the NRFTD Research Board. “It is always difficult for our reviewers to choose among them, but we feel that the ones selected for support in this cycle were particularly noteworthy. We are fortunate that our donors were generous enough this year to allow us to fund four projects – projects that we hope will eventually translate into tangible benefits for patients.”
The four $60,000 grant winners were selected following a rigorous peer-review process by the NRFTD’s distinguished Scientific Advisory Board, using guidelines similar to those established by the National Institutes of Health. Three ad hoc reviewers from leading national academic institutions provided additional expertise in the review of the applications.
Dr. Brian Stevenson, a Professor at the University of Kentucky’s Department of Microbiology, Immunology and Molecular Genetics, has been awarded a grant to study the influence of a newly-discovered protein, called EbfC, on gene expression in Borrelia burgdorferi, the causative agent of Lyme disease. Vector-borne pathogens like B. burgdorferi are transmitted back and forth between hosts and need to sense and respond to their environment by upregulating expression of certain proteins while suppressing others, depending on their current host environment, in order to enhance their chance for survival. Dr. Stevenson has discovered that EbfC, a site-specific DNA-binding protein, regulates expression of over 5
'/>"/>
| Source: PRWeb Copyright©2012 Vocus, Inc. All rights reserved |
Related medicine news :
1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
5. Sexually abused boys at risk for more unsafe sex: UBC research
6. Researchers Find Gene Mutations That May Be a Key to Autism
7. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
8. Researchers find evidence of banned antibiotics in poultry products
9. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
10. Scientific session and new research highlights
11. NJ stroke researchers report advances in spatial neglect research at AAN Conference
Post Your Comments:
(Date:6/19/2013)... 2013 Weight gain and obesity have ... concerns including heart disease, kidney failure and high blood ... excess and unnecessary fat, have many people searching for ... hCG diets to not only allow patients to ... also aim to reduce the risk for many weight-related ...
(Date:6/19/2013)... To survive when your plane goes down on a combat mission, ... the most important item in a survival kit is not a ... Kleyne Hour Power of Water radio show, Orr stated that in ... ahead of guns or even food. , According to Orr, the ... carry on planes in Vietnam. He was the only Navy pilot ...
(Date:6/19/2013)... New York,NY (PRWEB) June 19, 2013 ... company officials at SizeItUp formally announced the ... This smartly renovated van is the latest entry in ... for the year 2013. The completely redesigned 2012 Nissan ... the automobile lovers and critics alike. , Provided with ...
(Date:6/19/2013)... McGuff Pharmaceuticals, Inc. continues to ... (ANDA) for Hydroxyprogesterone Caproate Injection, USP 250mg/mL, 5mL, multiple ... fomerly known as Delalutin™. We are providing this ... approval and market introduction dates for McGuff’s Hydroxyprogesterone Caproate ... our pending ANDA, to date, McGuff has responded to ...
(Date:6/19/2013)... 2013 Audibel Hearing Center is ... tinnitus patients, the A2 with Multiflex Tinnitus Technology. ... ringing in the ears. Although bothersome, tinnitus usually ... body. , Using their patent-pending Multiflex Tinnitus Technology, ... comforting sound stimulus that resonates through the patient’s ...
Breaking Medicine News(10 mins):Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 3Health News:Vietnam Navy Pilot Reveals to Radio Host Sharon Kleyne That He Carried Extra Water Not a Gun in Survival Kit 2Health News:Rim Fitments Expert, SizeItUp Comes Up With Database Integrations For The 2012 Nissan NV 2Health News:Current Progress Towards ANDA Approval of Hydroxyprogesterone Caproate Injection, USP 2Health News:Audibel Hearing Center Introduces A2 with Multiflex Tinnitus Technology 2[0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns[0] Vietnam Navy Pilot Reveals to Radio Host Sharon Kleyne That He Carried Extra Water Not a Gun in Survival Kit[0] Rim Fitments Expert, SizeItUp Comes Up With Database Integrations For The 2012 Nissan NV[0] Current Progress Towards ANDA Approval of Hydroxyprogesterone Caproate Injection, USP[0] Audibel Hearing Center Introduces A2 with Multiflex Tinnitus Technology
... boost emotional well-being in hard times , , THURSDAY, May ... women may actually overspend to try to cheer themselves up, ... found that 79 percent said they,d go on a shopping ... listed "depression" and 60 percent listed "feeling a bit low" ...
... to Improve CBO Modeling and Information for PolicymakersWASHINGTON, ... Fight Chronic Disease policy briefing on Capitol Hill, ... James C. Capretta, M.A., released a white paper, ... Diseases: The Current Context and Potential Enhancements." ...
... Hospitalist Company, Inc. (Nasdaq: IPCM ), a leading national physician group practice company, announced today that management ... New York City., ... ... ...
... CITY, Calif., May 21 Genomic Health, Inc. (Nasdaq: ... will present results from three studies at the American ... May 29 - June 2, 2009, at the Orange ... markets the widely-adopted Onco type DX(R) breast cancer ...
... 21 Celator Pharmaceuticals today announced that it ... Inc. (Nasdaq: CEPH ). The ... application of Celator,s proprietary technology to an ongoing ... agreement provides an opportunity to leverage the technology ...
... the importance of hearing healthPISCATAWAY, N.J., May 21 ... Hearing Month in Times Square from ... air a 30-second hearing loss awareness video every hour on ... addition, 18 Siemens representatives will be in Times Square and ...
Cached Medicine News:Health News:Shop 'Til You Drop: You May Feel Better 2Health News:National Coalition Hosts Event to Examine Costs Projections for Chronic Diseases 2Health News:National Coalition Hosts Event to Examine Costs Projections for Chronic Diseases 3Health News:IPC The Hospitalist Company, Inc. to Present at Citi's 2009 Healthcare Services Day 2Health News:Genomic Health to Present Multiple New Studies at the American Society of Clinical Oncology Annual Meeting 2Health News:Genomic Health to Present Multiple New Studies at the American Society of Clinical Oncology Annual Meeting 3Health News:Celator(R) Pharmaceuticals Initiates Research Agreement With Cephalon, Inc. 2Health News:Siemens Promotes May is Better Speech and Hearing Month on America's Largest Stage 2Health News:Siemens Promotes May is Better Speech and Hearing Month on America's Largest Stage 3Shop 'Til You Drop: You May Feel BetterNational Coalition Hosts Event to Examine Costs Projections for Chronic DiseasesIPC The Hospitalist Company, Inc. to Present at Citi's 2009 Healthcare Services DayGenomic Health to Present Multiple New Studies at the American Society of Clinical Oncology Annual MeetingCelator(R) Pharmaceuticals Initiates Research Agreement With Cephalon, Inc.Siemens Promotes May is Better Speech and Hearing Month on America's Largest Stage
(Date:6/19/2013)... 19, 2013 Pharma IQ is pleased ... summary of the results from an industry survey conducted ... respondents stated that CROs would be an area of active ... be running 6 or more clinical trials in the BRIC ... Supply USA Summit explores the latest ...
(Date:6/18/2013)... , June 18, 2013 Valeant Pharmaceuticals International, ... (the "Company") announced today that VPII Escrow Corp., a ... has launched its offer of approximately $3.2 billion aggregate ... Notes will be due in 2021 and in 2023, ... Company intends to use the net proceeds from the ...
(Date:6/18/2013)... 2013 Actavis, Inc. (NYSE: ACT ) today ... U.S. Securities and Exchange Commission (SEC) a registration statement on ... Warner Chilcott plc (NASDAQ: WCRX ), which ... Chilcott (the "Form S-4"). As previously announced ... have entered into a definitive agreement pursuant to which Actavis ...
Breaking Medicine Technology:Pharma IQ Presents the Latest Trends in Clinical Trial Supply 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7... , WASHINGTON, Oct. 16 Pfizer Inc., through a wholly ... today in federal district court in Boston as part of ... fine for the illegal marketing of the painkiller Bextra for ... disregard a pharmaceutical company had for patients, lives by putting ...
... Oct. 16 Balch Hill Medical, Inc. of Hanover, ... PrecisionThread IV Catheter System, which is designed to increase ... According to the company, which grew out of the ... IV Catheter design dramatically reduces the two main causes ...
Cached Medicine Technology:Whistleblower's Attorney Says Pfizer's Guilty Plea Today Opens New Chapter on Aggressive Enforcement of Pharma Companies 2Dartmouth Medical School Faculty Member and Anesthesiologist Invents Revolutionary Catheter System Designed to Increase Rate of Successful IV Insertions by 75 Percent 2Dartmouth Medical School Faculty Member and Anesthesiologist Invents Revolutionary Catheter System Designed to Increase Rate of Successful IV Insertions by 75 Percent 3... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |